| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 17,408 | 16,502 | 16,532 | 14,713 |
| Cost of revenue | 1,766 | 1,742 | 1,526 | 1,461 |
| Gross profit | 15,642 | 14,760 | 15,006 | 13,252 |
| Research and development | 12,648 | 12,171 | 11,862 | 11,923 |
| Sales and marketing | 6,850 | 6,335 | 6,529 | 4,962 |
| General and administrative | 4,858 | 4,502 | 4,323 | 4,286 |
| Total operating expenses | 24,356 | 23,008 | 22,714 | 21,171 |
| Loss from operations | -8,714 | -8,248 | -7,708 | -7,919 |
| Interest expense | 49 | 42 | 48 | 55 |
| Other income (expense), net | 636 | 786 | 718 | 775 |
| Loss before income taxes and loss from equity method investment | -8,127 | -7,504 | -7,038 | -7,199 |
| Loss from equity method investment, net of tax | -484 | -780 | -815 | -580 |
| Provision for (benefit from) income taxes | 380 | 846 | 268 | -92 |
| Net loss | -8,991 | -9,130 | -8,121 | -7,687 |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | -0.21 | -0.22 | -0.2 | -0.2 |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | -0.21 | -0.22 | -0.2 | -0.2 |
| Weighted-average shares used in computing per share amounts, basic (in shares) | 42,743,518 | 41,819,427 | 40,853,048 | 39,295,743 |
| Weighted-average shares used in computing per share amounts, diluted (in shares) | 42,743,518 | 41,819,427 | 40,853,048 | 39,295,743 |
Arteris, Inc. (AIP)
Arteris, Inc. (AIP)